Search

You searched for "head and neck"

178 results found

What is the prognostic value of lymph node yield and density in head and neck cancer?

1 September 2018 | | head and neck cancer, lymph node ratio, lymph node yield, prognostic value, systematic review
Neck dissection in addition to surgery of the primary site is commonly recommended in head and neck cancer treatment. However, there has been no consensus on the number of nodes that need to be removed to constitute a sufficient neck...

Risk of second primary cancer among patients with head and neck cancers

1 October 2018 | | ENTA - Head & Neck
Patients with head and neck squamous cell carcinoma (HNSCC) have an elevated risk of developing a second primary malignant neoplasm (SPMN). These are of increasing concern because the number of survivors of HNSCC has been growing owing to early detection...
Dysphagia journal cover image.

Predicting swallowing outcomes post radiotherapy for head and neck cancer

7 January 2021 | | ENTA - Laryngology / Swallowing / Voice | Cancer, Deglutition, Deglutition disorders, Displacement, Dysphagia, Radiation, Timing
A videofluroscopic swallow study (VFSS), also known as modified barium swallow (MBS) offers a dynamic view of swallow biomechanics and associated swallowing physiology. The authors of this paper investigated whether quantitative timing and displacement measures of key structures involved in...
The Laryngoscope journal cover image.

Pre-habilitation in head and neck cancer – a literature review to guide best practice

4 March 2024 | | ENTA - Head & Neck
Curative treatment of head and neck cancer (HNC) often requires surgery; however, outcomes are impacted by the complexity of the surgery and the patient population. Increasingly ‘Enhanced Recovery After Surgery’ (ERAS) protocols are being used to maximise patient outcomes and...
Laryngology & Otology journal cover image.

A safe management pathway for low-risk head and neck cancer suspected referrals

3 September 2024 | | ENTA - Head & Neck
Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...

Treatment regret in head and neck cancer – trading function for survival

2 July 2025 | | ENTA - Head & Neck
Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a form of decision regret, involving...

C2Dx acquires otolaryngology/head and neck surgery products from Cook Medical

21 May 2024 | Contracts & Distributors, Company Profiles
C2Dx Inc., a medical device company based in the U.S., has acquired the otolaryngology/head and neck surgery (“OHNS”) family of products from Cook Medical.
Otolaryngologic Clinics cover image.

Which patients are suitable for surgery in recurrent head and neck cancer?

4 November 2025 | | ENTA - Head & Neck
Currently, radiotherapy and chemotherapy is the most common modality used in the management of primary head and neck squamous cell carcinomas (HNSCC). Unfortunately, around 50% of patients experience disease recurrence (rHNSCC). Surgery is therefore often used as a salvage treatment....

Robotic head and neck surgery: current state of the art and future innovations

1 March 2016 | | ENTA - Head & Neck
Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Head and neck cancer deaths to cost $535 billion by 2030

3 March 2021 | | ENTA - Head & Neck
More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...

‘Drop-in’ nasendoscopy – a decade of development to find head and neck cancer early

7 January 2026 | | ENTA - Head & Neck, ENTA - Laryngology / Swallowing / Voice
A decade of innovation in digital, remote endoscopy is paving the way for ‘drop-in’ nasendoscopy, improving early head and neck cancer diagnosis in high-risk communities. In May 2026, the University Hospitals North Midlands (UHNM) will inaugurate its newly established clinical...